What is OMCL's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 1.61B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for OMCL?

P/E (TTM) is 41.77 and 52-week range is $29.06 to $55.00 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s OMCL figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for OMCL?

The company profile lists revenue (TTM) near $1.22B, net income (TTM) near $38M, EPS (TTM) near $0.85 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Omnicell Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Fort Worth, Texas, US, 45.5M shares outstanding, ISIN US68213N1090 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Free AI scores & summaries library

Omnicell Inc

$OMCL

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$35.39

-1.56%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Fort Worth, Texas and currently employs 3,580 full-time employees. The company went IPO on 2001-08-08. The firm is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. The company provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. The company provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.

Employees

3,580

Website

www.omnicell.com/

IPO

2001-08-08

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)